<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35099786</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>02</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1179-6901</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>22</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Drugs in R&amp;D</Title>
          <ISOAbbreviation>Drugs R D</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Pharmacokinetics of Diazepam and Its Metabolites in Urine of Chinese Participants.</ArticleTitle>
        <Pagination>
          <StartPage>43</StartPage>
          <EndPage>50</EndPage>
          <MedlinePgn>43-50</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s40268-021-00375-y</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Urine is conventionally used as a specimen to document diazepam-related crimes; however, few reports have described the pharmacokinetics of diazepam and its metabolites in urine.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aimed to investigate the pharmacokinetics of diazepam and its metabolites, including glucuronide compounds, in the urine of Chinese participants.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A total of 28 volunteers were recruited and each participant ingested 5 mg of diazepam orally. Ten milliliters of urine were collected from each participant at post-consumption timepoints of prior (zero), 1, 2, 4, 8, 12, and 24 h and 2, 3, 6, 12, and 15 days. All samples were extracted by solid-phase extraction and analyzed using high-performance liquid chromatography-tandem mass spectrometry. Diazepam and its main metabolites, except for temazepam, were detected in the urine of volunteers. Pharmacokinetic parameters were analyzed using the pharmacokinetic software DAS according to the non-compartment model.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Urinary diazepam peaked at 2.38 ng/mL (C<sub>max</sub>) and 1.93 h (T<sub>max</sub>). The urinary metabolite nordiazepam peaked at 1.17 ng/mL and 100.21 h; temazepam glucuronide (TG) peaked at 145.61 ng/mL and 41.14 h; and oxazepam glucuronide (OG) peaked at 101.57 ng/mL and 165.86 h. The elimination half-life (t<sub>½z</sub>) and clearance (CLz/F) for diazepam were 119.58 h and 65.77 L/h, respectively. The t<sub>½z</sub> of the metabolites nordiazepam, TG, and OG was 310.58 h, 200.17 h, and 536.44 h, respectively. Finally, this study found that both diazepam and its main metabolites in urine were detectable for at least 15 days, although there were individual differences.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results regarding diazepam pharmacokinetics in urine would be of great help in forensic science and drug screening.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Le-le</ForeName>
            <Initials>LL</Initials>
            <AffiliationInfo>
              <Affiliation>School of Forensic Medicine, Shanxi Medical University, Jinzhong, 030600, Shanxi, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Forensic Toxicology of Ministry of Public Security, Jinzhong, 030600, Shanxi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ren</LastName>
            <ForeName>Xin-Xin</ForeName>
            <Initials>XX</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Forensic Science, Ministry of Public Security, Beijing, 100038, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>He</LastName>
            <ForeName>Yi</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Forensic Science, Ministry of Public Security, Beijing, 100038, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cui</LastName>
            <ForeName>Guan-Feng</ForeName>
            <Initials>GF</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Forensic Science, Ministry of Public Security, Beijing, 100038, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Jia-Jia</ForeName>
            <Initials>JJ</Initials>
            <AffiliationInfo>
              <Affiliation>School of Forensic Medicine, Shanxi Medical University, Jinzhong, 030600, Shanxi, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Forensic Toxicology of Ministry of Public Security, Jinzhong, 030600, Shanxi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jia</LastName>
            <ForeName>Juan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>School of Forensic Medicine, Shanxi Medical University, Jinzhong, 030600, Shanxi, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Forensic Toxicology of Ministry of Public Security, Jinzhong, 030600, Shanxi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cao</LastName>
            <ForeName>Jie</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>School of Forensic Medicine, Shanxi Medical University, Jinzhong, 030600, Shanxi, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Forensic Toxicology of Ministry of Public Security, Jinzhong, 030600, Shanxi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Yao</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>School of Forensic Medicine, Shanxi Medical University, Jinzhong, 030600, Shanxi, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Forensic Science, Ministry of Public Security, Beijing, 100038, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cong</LastName>
            <ForeName>Bin</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>School of Forensic Medicine, Shanxi Medical University, Jinzhong, 030600, Shanxi, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Forensic Medicine, Hebei Medical University, Shijiazhuang, 050017, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wei</LastName>
            <ForeName>Zhi-Wen</ForeName>
            <Initials>ZW</Initials>
            <AffiliationInfo>
              <Affiliation>School of Forensic Medicine, Shanxi Medical University, Jinzhong, 030600, Shanxi, China. weizhiwen2000@163.com.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Forensic Toxicology of Ministry of Public Security, Jinzhong, 030600, Shanxi, China. weizhiwen2000@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yun</LastName>
            <ForeName>Ke-Ming</ForeName>
            <Initials>KM</Initials>
            <AffiliationInfo>
              <Affiliation>School of Forensic Medicine, Shanxi Medical University, Jinzhong, 030600, Shanxi, China. yunkeming5142@163.com.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Forensic Toxicology of Ministry of Public Security, Jinzhong, 030600, Shanxi, China. yunkeming5142@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>01</Month>
          <Day>31</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Drugs R D</MedlineTA>
        <NlmUniqueID>100883647</NlmUniqueID>
        <ISSNLinking>1174-5886</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>67220MCM01</RegistryNumber>
          <NameOfSubstance UI="D003708">Nordazepam</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>Q3JTX2Q7TU</RegistryNumber>
          <NameOfSubstance UI="D003975">Diazepam</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002851" MajorTopicYN="N">Chromatography, High Pressure Liquid</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003975" MajorTopicYN="Y">Diazepam</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
          <QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003708" MajorTopicYN="Y">Nordazepam</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
          <QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D052616" MajorTopicYN="N">Solid Phase Extraction</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>Le-le Wang, Xin-xin Ren, Yi He, Guan-feng Cui, Jia-jia Liu, Juan Jia, Jie Cao, Yao Liu, Bin Cong, Zhi-wen Wei, and Ke-ming Yun declare they have no conflicts of interest in relation to this work.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>31</Day>
          <Hour>12</Hour>
          <Minute>18</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35099786</ArticleId>
        <ArticleId IdType="pmc">PMC8885946</ArticleId>
        <ArticleId IdType="doi">10.1007/s40268-021-00375-y</ArticleId>
        <ArticleId IdType="pii">10.1007/s40268-021-00375-y</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Woods JH, Katz JL, Winger G. Benzodiazepines: use, abuse, and consequences. Pharmacol Rev. 1992;44:151–347.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1356276</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin IL. The benzodiazepines and their receptors: 25 years of progress. Neuropharmacology. 1987;26:957–970. doi: 10.1016/0028-3908(87)90074-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0028-3908(87)90074-8</ArticleId>
            <ArticleId IdType="pubmed">2821436</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lim JY, Lee DH. Characteristics of drugs ingested for suicide attempts in the elderly. J Korean Med Sci. 2018;33:e86. doi: 10.3346/jkms.2018.33.e86.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3346/jkms.2018.33.e86</ArticleId>
            <ArticleId IdType="pmc">PMC5835585</ArticleId>
            <ArticleId IdType="pubmed">29495136</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li F, Chen Y, Gong B, Ruan L, Li H, Tang W, Liu W, Ynag H. Investigation on drug use and driving of patients with mental disorders. J Clin Psychiatr. 2016;26(01):51.</Citation>
        </Reference>
        <Reference>
          <Citation>Lugoboni F, Morbioli L. Benzodiazepine abuse in the attention deficit hyperactivity disorder. A case report. J Clin Psychopharm. 2018;38:402–404. doi: 10.1097/JCP.0000000000000903.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/JCP.0000000000000903</ArticleId>
            <ArticleId IdType="pubmed">29901561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Costa E.  The benzodiazepines: from molecular biology to clinical practice. New York: Raven Press; 1983. </Citation>
        </Reference>
        <Reference>
          <Citation>Dinis-Oliveira RJ. Metabolic profile of oxazepam and related benzodiazepines: clinical and forensic aspects. Drug Metab Rev. 2017;49:451–463. doi: 10.1080/03602532.2017.1377223.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/03602532.2017.1377223</ArticleId>
            <ArticleId IdType="pubmed">28903606</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lennestal R, Lakso HA, Nilsson M, Mjorndal T. Urine monitoring of diazepam abuse- new intake or not? J Anal Toxicol. 2008;32:402–407. doi: 10.1093/jat/32.6.402.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jat/32.6.402</ArticleId>
            <ArticleId IdType="pubmed">18652745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith-Kielland A, Skuterud B, Olsen KM, Morland J. Urinary excretion of diazepam metabolites in healthy volunteers and drug users. Scand J Clin Lab Invest. 2001;61:237–246. doi: 10.1080/003655101300133676.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/003655101300133676</ArticleId>
            <ArticleId IdType="pubmed">11386610</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Temte V, Kjeldstadli K, Bruun LD, Birdal M, Bachs L, Karinen R, et al.  An experimental study of diazepam and alprazolam kinetics in urine and oral fluid following single oral doses. J Anal Toxicol. 2019;43:104–111. doi: 10.1093/jat/bky062.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jat/bky062</ArticleId>
            <ArticleId IdType="pubmed">30517712</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marland A, Sarkar P, Leavitt R. The urinary elimination profiles of diazepam and its metabolites, nordiazepam, temazepam, and oxazepam, in the Equine after a 10-mg intramuscular dose. J Anal Toxicol. 1999;23:29–34. doi: 10.1093/jat/23.1.29.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jat/23.1.29</ArticleId>
            <ArticleId IdType="pubmed">10022206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chiba K, Horii H, Chiba T, Kato Y, Hirano T, Ishizaki T. Development and preliminary application of high-performance liquid chromatographic assay of urinary metabolites of diazepam in humans. J Chromatogr B Biomed Appl. 1995;668:77–84. doi: 10.1016/0378-4347(95)00050-S.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0378-4347(95)00050-S</ArticleId>
            <ArticleId IdType="pubmed">7550984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Umezawa H, Lee XP, Arima Y, Hasegawa C, Marumo A, Kumazawa T, et al.  Determination of diazepam and its metabolites in human urine by liquid chromatography/tandem mass spectrometry using a hydrophilic polymer column. Rapid Commun Mass Spectrom. 2008;22:2333–2341. doi: 10.1002/rcm.3613.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/rcm.3613</ArticleId>
            <ArticleId IdType="pubmed">18618924</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schenk I, Machnik M, Broussou D, Meuly A, Roques BB, Lallemand E, et al.  Kinetic disposition of diazepam and its metabolites after intravenous administration of diazepam in the horse: relevance for doping control. J Vet Pharmacol Ther. 2021;44:733–744. doi: 10.1111/jvp.12991.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jvp.12991</ArticleId>
            <ArticleId IdType="pubmed">34115414</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang X, Wang R, Zhang Y, Liang C, Ye H, Cao F, et al.  Extending the detection window of diazepam by directly analyzing its glucuronide metabolites in human urine using liquid chromatography–tandem mass spectrometry. J Chromatogr A. 2012;1268:29–34. doi: 10.1016/j.chroma.2012.10.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chroma.2012.10.012</ArticleId>
            <ArticleId IdType="pubmed">23122274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang R, Wang X, Liang C, Ni C, Xiong L, Rao Y, et al.  Direct determination of diazepam and its glucuronide metabolites in human whole blood by μElution solid-phase extraction and liquid chromatography–tandem mass spectrometry. Forensic Sci Int. 2013;233:304–311. doi: 10.1016/j.forsciint.2013.10.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.forsciint.2013.10.004</ArticleId>
            <ArticleId IdType="pubmed">24314534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang L, Ren X, He Y, Cui G, Wei Z, Jia J, et al.  Study on the pharmacokinetics of diazepam and its metabolites in blood of Chinese people. Eur J Drug Metab Pharmacokinet. 2020;45:477–485. doi: 10.1007/s13318-020-00614-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13318-020-00614-8</ArticleId>
            <ArticleId IdType="pubmed">32219697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jones AW, Holmgren A, Holmgren P. High concentrations of diazepam and nordiazepam in blood of impaired drivers: association with age, gender and spectrum of other drugs present. Forensic Sci Int. 2004;146:1–07. doi: 10.1016/j.forsciint.2004.05.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.forsciint.2004.05.020</ArticleId>
            <ArticleId IdType="pubmed">15485715</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Friedman H, Greenblatt DJ, Peters GR, Metzler CM, Charlton MD, Harmatz JS, et al.  Pharmacokinetics and pharmacodynamics of oral diazepam: effect of dose, plasma concentration, and time. Clin Pharmacol Ther. 1992;52:139–150. doi: 10.1038/clpt.1992.123.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/clpt.1992.123</ArticleId>
            <ArticleId IdType="pubmed">1505149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Y, Reviriego J, Lou YQ, Sjöqvist F, Bertilsson L. Diazepam metabolism in native Chinese poor and extensive hydroxylators of S-mephenytoin: Interethnic differences in comparison with White subjects. Clin Pharmacol Ther. 1990;48:496–502. doi: 10.1038/clpt.1990.185.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/clpt.1990.185</ArticleId>
            <ArticleId IdType="pubmed">2225709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marcucci F, Guaitani A, Kvetina J, Mussini E, Garattini S. Species difference in diazepam metabolism and anticonvulsant effect. Eur J Pharmacol. 1968;4:467–470. doi: 10.1016/0014-2999(68)90036-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0014-2999(68)90036-8</ArticleId>
            <ArticleId IdType="pubmed">5724923</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gershkovich P, Wasan KM, Ribeyre C, Ibrahim F, Mcneill JH. Effect of variations in treatment regime and liver cirrhosis on exposure to benzodiazepines during treatment of alcohol withdrawal syndrome. Drugs Context. 2015;4:1–6. doi: 10.7573/dic.212287.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7573/dic.212287</ArticleId>
            <ArticleId IdType="pmc">PMC4544271</ArticleId>
            <ArticleId IdType="pubmed">26322116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peng J, Liu W. Research progress in the effect of CYP2C19 gene polymorphisms on drug metabolism. J Pharm Pract. 2015;33:508–512.</Citation>
        </Reference>
        <Reference>
          <Citation>Sakai N, Ishizuka M. Impact of rat P450 genetic polymorphism on diazepam metabolism. Expert Opin Drug Metab Toxicol. 2009;5:1421–1433. doi: 10.1517/17425250903207002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1517/17425250903207002</ArticleId>
            <ArticleId IdType="pubmed">19689220</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kosuge K, Jun Y, Watanabe H, Kimura M, Nishimoto M, Ishizaki T, et al.  Effects of CYP3A4 inhibition by diltiazem on pharmacokinetics and dynamics of diazepam in relation to CYP2C19 genotype status. Drug Metab Dispos. 2001;29:1284–1289.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11560871</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qin X, Zhang X, Zhou H. Difference of metabolism of diazepam between two groups of genotype. J Changzhi Med Coll. 1999;03:166–8.</Citation>
        </Reference>
        <Reference>
          <Citation>Özdemir M, Aktan Y, Boydaĝ BS, Cingi MI, Musmul A. Interaction between grapefruit juice and diazepam in humans. Eur J Drug Metab Pharmacokinet. 1998;23:55–59. doi: 10.1007/BF03189827.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF03189827</ArticleId>
            <ArticleId IdType="pubmed">9625273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perucca E, Gatti G, Cipolla G, Spina E, Barel S, Soback S, et al.  Inhibition of diazepam metabolism by fluvoxamine: a pharmacokinetic study in normal volunteers. Clin Pharmacol Ther. 1994;56:471–476. doi: 10.1038/clpt.1994.167.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/clpt.1994.167</ArticleId>
            <ArticleId IdType="pubmed">7955810</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McBurney L. Detection of diazepam and determination of time of ingestion. J Can Soc Forensic Sci. 1981;14:152–164. doi: 10.1080/00085030.1981.10756886.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/00085030.1981.10756886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fukasawa T, Suzuki A, Otani K. Effects of genetic polymorphism of cytochrome P450 enzymes on the pharmacokinetics of benzodiazepines. J Clin Pharm Ther. 2007;32:333–341. doi: 10.1111/j.1365-2710.2007.00829.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2710.2007.00829.x</ArticleId>
            <ArticleId IdType="pubmed">17635335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inomata S, Nagashima A, Itagaki F, Homma M, Nishimura M, Osaka Y, et al.  CYP2C19 genotype affects diazepam pharmacokinetics and emergence from general anesthesia. Clin Pharmacol Ther. 2005;78:647–655. doi: 10.1016/j.clpt.2005.08.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clpt.2005.08.020</ArticleId>
            <ArticleId IdType="pubmed">16338280</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
